MRAM specialist Everspin Technologies hits year-high stock price after inking major deal with semiconductor giant Microchip.

Table of Contents Everspin Technologies (MRAM) shares touched a fresh 52-week peak at $23.10 this past Friday, May 8, ultimately closing the session near $22.59. The closing price represents a substantial premium over both the 50-day moving average of $11.18 and the 200-day moving average of $10.63. Everspin Technologies, Inc., MRAM Trading activity for the session registered approximately 437,000 shares, marking an increase from the previous session’s close at $21.51. The semiconductor stock has appreciated roughly 25% in recent weeks, propelled primarily by a strategic manufacturing announcement made last month. On April 8, Everspin unveiled a 10-year manufacturing collaboration with Microchip Technology focused on producing MRAM and Tunnel Magnetoresistive (TMR) sensor solutions at Microchip’s Oregon production facility. Under the terms, Everspin retains full ownership of its intellectual property and manufacturing processes. The arrangement also provides ITAR-compliant wafer processing capabilities, a critical requirement for defense and aerospace applications. Everspin plans to maintain operations at its existing Chandler, Arizona fabrication plant simultaneously. Initial product shipments from the Oregon facility are anticipated during the latter half of 2027. The collaboration includes provisions for extension beyond the initial 10-year period in two-year increments. For the first quarter of 2026, Everspin delivered earnings per share of $0.11 alongside revenue of $14.87 million, surpassing analyst projections of $14.60 million. The company reported a net margin of 0.50% with return on equity at 4.78%. However, the second quarter 2026 outlook presents a more subdued picture. Management issued EPS guidance spanning $0.000 to $0.030 — an unusually broad and modest range suggesting near-term uncertainty. The company currently carries a market capitalization of $593 million, with a price-to-earnings ratio of 2,532 — underscoring the nascent stage of its profitability trajectory. Wall Street sentiment remains divided. Needham elevated its price objective from $14.00 to $18.50 while reaffirming a Buy rating on April 30. Conversely, Weiss Ratings maintained a Sell recommendation in March. Wall Street Zen moved from Buy to Hold in February. The consensus rating currently stands at Hold with an average price target of $18.50 — notably beneath current trading levels. Regarding insider transactions, CEO Sanjeev Aggarwal divested 28,459 shares at $19.58 per share on May 4, generating proceeds of approximately $557,000. This transaction reduced his ownership stake by 3.36%. CFO William Earl Cooper sold 11,000 shares at $21.75 on May 6, totaling $239,250 in proceeds — representing a 6.39% decrease in his holdings. Collectively, company insiders have sold roughly 60,448 shares valued at approximately $990,000 during the past three months. Institutional investors hold 44.68% of outstanding shares, with multiple hedge funds establishing fresh positions in recent quarters, including Raymond James Financial, Kestra Advisory Services, and Occudo Quantitative Strategies. The stock’s beta coefficient of 1.75 indicates elevated volatility relative to the broader equity market.